Loading stock data...
Bristol-Myers Squibb Company (BMY) Stock Price, Chart & Analysis
Bristol-Myers Squibb CompanyBMY
Market Closed$48.19
$-0.25-0.52%
BMY Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for BMY to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Bristol-Myers Squibb Company (BMY)
Loading chart data...
Is Bristol-Myers Squibb Company (BMY) Stock a Buy in 2025?
NO
UNDERPERFORM
Score: 43/100
No, BMY stock may not be the best buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether BMY stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Moderate revenue growth of 7.3%
- Healthy profit margins of 10.6%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 10.0% upside potential
- Mid-large cap with growth potential
Risk Factors
- High debt-to-equity ratio of 291.55
- Moderate current ratio suggests adequate liquidity
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:3
Hold Ratings:5
Sell Ratings:2
Avg. Price Target:$53.00
Upside Potential:10.0%
Investment Summary
BMY presents a mixed investment profile for 2025. The company shows strong growth drivers including moderate revenue growth of 7.3%, though analyst price targets suggest 10.0% upside potential.
Analyst sentiment is generally positive with 3 buy ratings vs 2 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 291.55, and consider their own risk tolerance and investment timeline.
Final Recommendation
UNDERPERFORM
Recommendation Score
Overall Score:43/100
Weak Hold
2030 Price Prediction
Predicted Price:$49.21
Potential Return:+2.1%
Key Factors
- Good revenue growth
- Some analyst support
- Moderate upside potential
- Wide analyst target range indicates uncertainty
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 52.0% (High)
Investment Decision
Based on our comprehensive analysis of BMY's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a UNDERPERFORM. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
bmy Stock Price Prediction 2030
Predicted 2030 Price
$49.21
+2.1%from current price
Based on revenue growth analysis and market trends, bmy stock is projected to reach $49.21 by 2030, representing a 2.1% increase from the current price of $48.19.
Current Price
$48.19
Revenue Growth
0.6%
Analyst Target
$53.00
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in bmy Stock?
Quick Investment Insights for bmy
Low Volatility (Beta: 0.37)Dividend: 5.12%
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Bristol-Myers Squibb Company
Healthcare
Drug Manufacturers - General
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology,...
Employees
34,100
Market Cap
$98.09B